Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Intermediate Purification via Ion-Exchange Chromatography – V 2.0

Posted on By


Biosimilars: SOP for Intermediate Purification via Ion-Exchange Chromatography – V 2.0


Standard Operating Procedure for Intermediate Purification via Ion-Exchange Chromatography in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/159/2025
Supersedes SOP/BS/159/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To describe the procedure for performing intermediate purification of biosimilar monoclonal antibodies using ion-exchange chromatography (IEX), ensuring removal of process impurities under GMP-compliant conditions.

2. Scope

This SOP is applicable to the use of both cation and anion exchange chromatography steps in downstream processing of biosimilar therapeutic proteins using pre-packed or in-house packed columns.

3. Responsibilities

  • Production: Set up IEX system, perform equilibration, sample loading, and elution.
  • QA: Review all batch records, IEX logs, and monitor compliance.
  • Engineering: Ensure skid, pump, and sensor calibration and maintenance.

4. Accountability

The DSP Lead is accountable for ensuring proper execution of intermediate purification using IEX and for overseeing all documentation.

5. Procedure

5.1 Column and Buffer Preparation

  1. Select appropriate resin (e.g., Q-Sepharose, SP Sepharose) based on process validation.
  2. Prepare and filter all required buffers:
    • Equilibration Buffer
    • Sample Buffer (pH-adjusted)
    • Wash Buffer (low salt)
    • Elution Buffer (NaCl gradient or stepwise)
    • Regeneration and Storage Buffers
  3. Record buffer pH, conductivity, and lot numbers in Annexure-1.

5.2 Column Setup and Equilibration

  1. Install column securely on the chromatography skid.
  2. Connect inlet and outlet tubing and verify correct direction of flow.
  3. Prime and equilibrate the column with 5–10 column volumes of equilibration buffer.
  4. Monitor UV, pH, and conductivity until stable baseline is achieved.

5.3 Sample Loading

  1. Transfer clarified and filtered feed to the loading tank.
  2. Set flow rate to 100–200 cm/hr based on column size and resin type.
  3. Monitor column pressure and UV absorbance at 280 nm during loading.
  4. Terminate loading when breakthrough is detected or sample is exhausted.

5.4 Washing and Elution

  1. Wash column with 3–5 CV of wash buffer to remove unbound impurities.
  2. Elute target protein using:
    • Linear gradient of NaCl (e.g., 0–500 mM over 10 CV), or
    • Step elution (predefined NaCl concentration)
  3. Monitor UV and collect fractions where product peak elutes.

5.5 Column Regeneration

  1. Wash column with high salt or alkaline buffer (e.g., 0.5 M NaOH) for 3–5 CV.
  2. Rinse thoroughly with WFI or storage buffer.
  3. Store column in 20% ethanol at 2–8°C if not reused immediately.

5.6 Documentation

  1. Record:
    • Column ID and resin lot
    • Buffer volumes and flow rates
    • UV chromatogram and collection timepoints
    • Any deviation or alerts triggered during run
  2. Complete Annexures 1 to 3 as part of the BMR.

6. Abbreviations

  • IEX: Ion Exchange Chromatography
  • CV: Column Volume
  • UV: Ultraviolet Absorbance
  • DSP: Downstream Processing

7. Documents

  1. Buffer Preparation Record – Annexure-1
  2. Chromatography Operation Log – Annexure-2
  3. Column Regeneration and Storage Log – Annexure-3

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO TRS 999 – GMP for Biotherapeutics
  • OEM Manuals – Cytiva IEX Columns, Repligen, Sartorius Systems

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Buffer Preparation Record

Buffer pH Conductivity Volume Prepared By Date
Elution Buffer 7.5 42 mS/cm 10 L Sunita Reddy 04/05/2025

Annexure-2: Chromatography Operation Log

Step Flow Rate Pressure UV (280nm) Start Time End Time Operator
Loading 125 cm/hr 1.2 bar 0.6 AU 10:00 10:45 Ajay Verma

Annexure-3: Column Regeneration and Storage Log

Date Column ID Regeneration Solution Contact Time Storage Buffer Stored At
04/05/2025 IEX-Q-01 0.5 M NaOH 30 min 20% ethanol 2–8°C

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added buffer conductivity control and UV breakthrough monitoring Process harmonization
See also  Biosimilars: SOP for Buffer Preparation for Harvest Operations - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Uncontrolled Revision of Documents Without QA Approval: A GMP Compliance Risk
Next Post: Analytical Method Development: SOP for Comparative Dissolution Profile (CDP) Development – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version